Processa Pharmaceuticals, Inc. Public Float
Processa Pharmaceuticals, Inc. (PCSA) had Public Float of $8.10 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $8.10M.
- 2024-06-28: Entity Public Float $5.80M.
- 2023-06-30: Entity Public Float $10.20M.
- 2022-06-30: Entity Public Float $33.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $8.10M 10-K/A · filed 2026-04-30 |
| 2024-06-28 | $5.80M 10-K · filed 2025-03-20 |
| 2023-06-30 | $10.20M 10-K · filed 2024-03-29 |
| 2022-06-30 | $33.80M 10-K · filed 2023-03-30 |
| 2021-06-30 | $95.40M 10-K/A · filed 2022-05-02 |
| 2020-06-30 | $22.00M 10-K · filed 2021-03-25 |
| 2019-06-28 | $44.80M 10-K · filed 2020-03-06 |
| 2018-06-30 | $25.30M 10-K/A · filed 2019-04-08 |
| 2017-06-30 | $1.00M 10-K · filed 2018-04-16 |
| 2016-06-30 | $1.45M 10-K · filed 2017-09-25 |
| 2015-06-30 | $3.95M 10-K · filed 2017-06-19 |
| 2014-06-30 | $7.76M 10-K · filed 2015-04-14 |
| 2013-12-31 | $4.59M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |